William J. Sandborn, See Remarks at Ventyx Biosciences, Inc. (VTYX), sold 85,364 shares at $33.87 ($2.9M) on 2022-12-14, disclosed to the SEC on 2022-12-16.
Open-market sale of $2.9M VTYX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.87 | 20,922 | $709K | 24.5% |
| 2 | $33.87 | 20,922 | $709K | 24.5% |
| 3 | $33.87 | 21,760 | $737K | 25.5% |
| 4 | $33.87 | 21,760 | $737K | 25.5% |
| Total | $33.87 avg | 85,364 | $2.9M | 100% |
| Filing → |
| VTYX | SELL | 2023-08-01 | $884K | — | Filing → |
| VTYX | SELL | 2023-07-05 | $615K | — | Filing → |
| VTYX | SELL | 2023-06-27 | $706K | — | Filing → |